Biotech SK Biopharmaceuticals Launches Joint Venture with Eurofarma for AI-based Epilepsy Management Platform October 21, 2025
Biotech FDA Grants Orphan Drug Designation to Cellenkos’ CK0803 Tregs for Treatment of Amyotrophic Lateral Sclerosis October 20, 2025
Biotech PADCEV™ Plus KEYTRUDA™, Given Before and After Surgery, Cuts the Risk of Recurrence, Progression or Death by 60% and the Risk of Death by 50% for Certain Patients with Bladder Cancer October 19, 2025
Biotech FDA approves expanded pediatric indications for YUFLYMA® (adalimumab-aaty) and unbranded adalimumab-aaty in the United States October 17, 2025
Biotech HistoIndex to debut FibroSIGHT™ Plus and showcase latest scientific findings at AASLD The Liver Meeting® 2025 October 15, 2025
Biotech 10x Faster Virus Neutralization Testing With Launch of Integral Molecular’s Ready Reporter Virus™ Kit October 14, 2025
Biotech EY announces the acquisition of Aqurance to accelerate life science transformation on Veeva technology October 13, 2025
Biotech C-Ray Therapeutics (Chengdu) Co., Ltd Congratulates Partner Biokin Pharmaceutical on NMPA IND Approval of First Proprietary ARC Drug [177Lu]-BL-ARC001 October 12, 2025
Search
Biotech
October 21, 2025
October 20, 2025
October 19, 2025
October 18, 2025
October 17, 2025
October 16, 2025
October 15, 2025
October 14, 2025
October 13, 2025
![C-Ray Therapeutics (Chengdu) Co., Ltd Congratulates Partner Biokin Pharmaceutical on NMPA IND Approval of First Proprietary ARC Drug [177Lu]-BL-ARC001](https://upalpha.com/wp-content/uploads/2025/10/ed4f1494fcc2c4355509c8ccab5a4d12-336x223.jpg)
October 12, 2025
